Article Text

Download PDFPDF
Plaque brachytherapy for choroidal melanoma with vitreous haemorrhage: a therapeutic challenge
  1. Subina Narang1,
  2. Awadhesh Kumar Pandey2,
  3. Mannat Giran1 and
  4. Ravinder Kaur3
  1. 1Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India
  2. 2Department of Radiotherapy and Oncology, Government Medical College and Hospital, Chandigarh, India
  3. 3Department of Radiodiagnosis, Government Medical College and Hospital, Chandigarh, India
  1. Correspondence to Dr Subina Narang; subina_navya{at}yahoo.com

Abstract

A 47-year-old man presented with profound loss of vision in right eye and relative afferent pupillary defect. On fundus examination, posterior pole details were obscured due to dense vitreous haemorrhage. B-scan ultrasonography was performed that revealed a mushroom-shaped hyperechoic lesion with medium internal reflectivity on A-scan ultrasonography. After performing contrast-enhanced MRI of the orbit, a diagnosis of choroidal melanoma was established. Patient was managed using plaque brachytherapy based on multiplanar MRI. This was followed 10 months later by pars plana vitrectomy and cataract extraction. Vision postoperatively improved to 20/60. A systematic clinical assessment along with supportive ancillary investigations augments diagnostic accuracy and reduces delay in definitive management.

  • cancer - see oncology
  • cancer intervention
  • eye

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors Concept, treating surgeon, writing the case report: SN; plaque planning: AKP; editing manuscript data acquisition: MG; compiling and writing, radiological investigations and editing: RK.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.